CRM197-conjugated peptides vaccine of HCMV pp65 and gH induce maturation of DC and effective viral-specific T cell responses

Human cytomegalovirus (HCMV) infection is prevalent worldwide, and there is currently no licenced HCMV vaccine to control it. Therefore, developing an effective HCMV vaccine is a significant priority. Because of their excellent immunogenicity, the crucial components of HCMV, phosphoprotein 65 (pp65)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuyun, Nan, Fulong, Jiang, Shasha, Zhou, Xiaoqiong, Niu, Delei, Li, Jun, Wang, Hui, Zhang, Xueming, Zhang, Xianjuan, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897769/
https://www.ncbi.nlm.nih.gov/pubmed/36723437
http://dx.doi.org/10.1080/21505594.2023.2169488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897769/
https://www.ncbi.nlm.nih.gov/pubmed/36723437
http://dx.doi.org/10.1080/21505594.2023.2169488

Ejemplares similares